Injae Shin Selected Research

1-phenyl-3,3-dimethyltriazene (PDT)

9/2020

Cancer cell death using metabolic glycan labelling techniques.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Injae Shin Research Topics

Disease

21	Neoplasms (Cancer) 10/2023 - 03/2015
4	Pathologic Processes 10/2022 - 01/2012
3	Inflammation (Inflammations) 01/2023 - 09/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 07/2003
2	Neoplasm Metastasis (Metastasis) 09/2021 - 12/2020
2	Melanoma (Melanoma, Malignant) 04/2021 - 11/2020
2	Lung Neoplasms (Lung Cancer) 11/2020 - 01/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Gout 01/2023
1	Infections 09/2021
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 08/2021
1	Brain Injuries (Brain Injury) 08/2021
1	Pain (Aches) 08/2021
1	Glioma (Gliomas) 12/2020
1	Glioblastoma (Glioblastoma Multiforme) 12/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Carcinogenesis 01/2019
1	Leukemia 01/2017
1	Neuroblastoma 10/2015
1	Arthritis (Polyarthritis) 09/2015
1	Experimental Arthritis 09/2015
1	Rheumatoid Arthritis 09/2015
1	Cystic Fibrosis (Mucoviscidosis) 12/2011

Drug/Important Bio-Agent (IBA)

6	apoptozoleIBA 11/2021 - 12/2011
5	Polysaccharides (Glycans)IBA 10/2022 - 01/2012
5	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2012
4	N- (4- methyl- 3- (1- methyl- 7- (6- methylpyridin- 3- ylamino)- 2- oxo- 1,2- dihydropyrimido(4,5- d)pyrimidin- 3(4H)- yl)phenyl)- 3- (trifluoromethyl)benzamideIBA 04/2021 - 01/2018
3	Phosphotransferases (Kinase)IBA 01/2019 - 01/2017
2	CaspasesIBA 12/2021 - 01/2017
2	VemurafenibIBA 04/2021 - 11/2020
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2021 - 01/2021
2	PLX8394IBA 04/2021 - 11/2020
2	AgarIBA 12/2020 - 11/2020
2	Chloride Channels (Chloride Channel)IBA 12/2020 - 12/2011
1	Glycoside Hydrolases (Endoglycosidases)IBA 10/2023
1	Colchicine FDA LinkGeneric 01/2023
1	Uric Acid (Urate)IBA 01/2023
1	InflammasomesIBA 01/2023
1	Coloring Agents (Dyes)IBA 10/2022
1	Cathepsin LIBA 03/2022
1	EnzymesIBA 03/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 03/2022
1	calix(4)pyrroleIBA 12/2021
1	CationsIBA 12/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2021
1	myricetinIBA 11/2021
1	Brefeldin AIBA 11/2021
1	Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone (FCCP)IBA 11/2021
1	2-phenylacetylenesulfonamideIBA 11/2021
1	AgmatineIBA 08/2021
1	Arginine (L-Arginine)FDA Link 08/2021
1	Morphine (MS Contin)FDA LinkGeneric 08/2021
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	lysosomal proteinsIBA 01/2021
1	Cathepsin BIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	PF-562271IBA 01/2021
1	CalciumIBA 12/2020
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2020
1	Cytochromes c (Cytochrome c)IBA 11/2019
1	SurvivinIBA 11/2019
1	AnionsIBA 08/2019
1	satraplatin (JM 216)IBA 01/2019
1	Pyruvic Acid (Pyruvate)IBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	triphenylphosphoniumIBA 10/2018
1	mortalinIBA 10/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2017
1	geldanamycinIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2016
1	imidazoleIBA 10/2015
1	trichostatin A (A 300)IBA 10/2015
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2015
1	thiamet GIBA 09/2015
1	AcetylglucosamineIBA 09/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2015
1	Adenosine Triphosphatases (ATPase)IBA 03/2015
1	ZincIBA 01/2014
1	Phenylalanine (L-Phenylalanine)FDA Link 12/2011
1	AntioxidantsIBA 07/2003
1	N-t-butyl-N-hydroxylaminophenylIBA 07/2003

Therapy/Procedure

3	Therapeutics 10/2022 - 03/2015
1	Photochemotherapy (Photodynamic Therapy) 09/2020